KDA-Asia Pacific region Webinar on the Recent Treatment of Diabetes 2021
(KAPD 2021)
‘The Expanding Role of SGLT2 inhibitor in Asian Patients with T2D’
Faculty
in program
Prof. Kunho Yoon
The Catholic University of Korea
Korea
Prof. Chaicharn Deerochanawong
Rangsit University
Thailand
Prof. Daisuke Yabe
Gifu University
Japan
Prof. Sunghee Choi
Seoul National University
Korea
Prof. Changhee Jung
University of Ulsan
Korea
Programme
Friday 23 April 2021 (KST)
18:30 - 18:50 (KST)
Introduction
Use of SGLT2i in Asian Patients with T2D and Cario-Renal Diseases
Professor Kunho, YOON
(CV)
18:50 - 19:00
Topic 1 (Commentary)
Interesting Questions about SGLT-2-I Usage
Prof. Chaicharn Deerochanawong (Facilitator)
(CV)
19:00 - 19:20
Topic 1 (Lecture)
MOA of SGLT2i in the Aspect of Cardio-Renal-Metabolic (CRM) Benefit
Prof. Daisuke Yabe (Speaker)
(CV)
19:20 - 19:30
Topic 2 (Commentary)
To Identify the Multiple Roles of SGLT2i in Each Region
Prof. Sung Hee CHOI (Facilitator)
(CV)
19:30 - 19:50
Topic 2 (Lecture)
Reducing Cardio-Renal Risk with SGLT2i in Patients with T2D: Interpreting the Evidence in Asia's Perspectives
Prof. Changhee JUNG (Speaker)
(CV)
19:50 - 20:20
Q&A
Discussion
20:20 - 20:30
Closing
What is the Best Treatment for T2D in terms of the CRM Diseases?
Kunho Yoon (Chairperson)
Webinar Office
#1007, Queen’s Park 12th 194, Gonghang-daero, Gangseo-gu, Seoul (07631), Republic of Korea
82-2-6734-1011
